Relsys International and Intrasphere Technologies announce strategic alliance

Collaboration between leading drug safety solutions provider and consulting firm will benefit life science industry clients

May 22, 2007 — /PRNewswire/ — IRVINE, CA and NEW YORK, NY — Relsys International and Intrasphere Technologies have announced a strategic partnership to offer joint solutions to the pharmaceutical and biotechnology industries. Relsys is the leading provider of software solutions for adverse event reporting, pharmacovigilance, and risk management, while Intrasphere is a consulting firm that provides business-focused services and solutions to life sciences organizations. The collaboration will benefit life science companies by offering best-of-breed solutions to address global regulatory compliance needs and to improve key business processes.

Dave Bajaj, president and CEO of Relsys International, said, “In our twentieth anniversary year, Relsys continues to offer innovative solutions to solve the life science industry’s most pressing needs. By partnering with a leader like Intrasphere, we expect that our clients will benefit from our mutual expertise in regulatory compliance and business process improvement.” Sanket Agrawal, Relsys’ chief strategy officer, added, “The pharmaceutical industry is increasingly looking towards vendors to provide end-to-end safety solutions: from appropriate strategy to efficient processes to effective software applications. This alliance delivers such an offering for our clients and allows them to focus more on Science, their core business.”

Relsys will be showcasing its latest innovations, such as Argus Perceptive(TM) for complete signal detection capability, at the DIA Annual Meeting in Atlanta, GA at booth #1127.

About Relsys International
Relsys International provides the industry-leading Argus suite, a complete systems solution for pharmacovigilance and risk management that helps pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients’ corporate risk management strategies. Argus Safety(TM), the company’s flagship product, is the world’s best selling adverse event reporting software, and is used by more of the leading pharmaceutical companies than any other solution. Relsys is a privately held company, headquartered in Irvine, CA. For more information, visit, or call +1-949-453-1715.

About Intrasphere Technologies
Intrasphere Technologies, Inc. ( is a consulting firm focused on the life sciences industry. We provide comprehensive, business-focused services that help companies achieve meaningful results. Our professionals leverage strategic acumen, deep industry knowledge and proven project execution abilities to deliver superior service that builds true business value. Our strategy, business process and technology services are developed to specifically address areas that are most important to our clients including: Drug Safety, Business Intelligence, Enterprise Content Management, Compliance and IT Management, to name a few. We understand the unique nature of the Life Sciences working environment and clients’ need to reduce costs, drive business processes and speed-to-market, while satisfying regulatory mandates. Some of the world’s leading global pharmaceutical companies look to Intrasphere as their trusted solutions partner. Founded in 1996, Intrasphere is headquartered in New York City with operations in Europe and Asia. Intrasphere has been recognized nationally for performance by industry leading organizations such as Deloitte & Touche, Crain’s New York Business and Inc. Magazine. For more information call (212) 937-8200.

Source: Relsys International; Intrasphere Technologies

Relsys International, +1-949-453-1715
or Intrasphere Technologies, +1-212-937-8200


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.